Kyung Mi Jang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kyung Mi Jang has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Seong Hyun Kim
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
6 shared publicationsDong Ik Cha
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Korea
5 shared publicationsTae Wook Kang
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Korea
5 shared publicationsYoung Kon Kim
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
4 shared publicationsD.I. Cha
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
3 shared publicationsKyoung Doo Song
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro Gangnam-gu, Seoul, 06351, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 1 January 2020
- Published by XMLink in Korean Journal of Radiology
- Vol. 21 (4) , 402-412
Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients
Cha DI, et al. Korean J Radiol. 2020 Feb;21:e30. https://doi.org/10.3348/kjr.2019.0538
- 1 January 2020
- Published by XMLink in Korean Journal of Radiology
- Vol. 21 (4) , 402-412
Open AccessPreoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients
Cha DI, et al. Korean J Radiol. 2020 Feb;21:e30. https://doi.org/10.3348/kjr.2019.0538
- 27 February 2019
- Published by Elsevier in Clinical Radiology
- Vol. 74 (5) , 406.e19-406.e27
Questionable correlation of the apparent diffusion coefficient with the histological grade and microvascular invasion in small hepatocellular carcinoma
- 27 February 2019
- Published by Elsevier in Clinical Radiology
- Vol. 74 (5) , 406.e19-406.e27
Questionable correlation of the apparent diffusion coefficient with the histological grade and microvascular invasion in small hepatocellular carcinoma
- 7 November 2018
- Published by Springer Nature in Abdominal Radiology
- Vol. 44 (4) , 1350-1360
Differences in early imaging features and pattern of progression on CT between intrahepatic biliary metastasis of colorectal origin and intrahepatic non-mass-forming cholangiocarcinoma in patients with extrabiliary malignancy
To assess the differences in early imaging features and progression pattern on CT between intrahepatic biliary metastasis (IBM) and non-mass-forming cholangiocarcinoma (NMFC) in patients with extrabiliary malignancy.
- 7 November 2018
- Published by Springer Nature in Abdominal Radiology
- Vol. 44 (4) , 1350-1360
Differences in early imaging features and pattern of progression on CT between intrahepatic biliary metastasis of colorectal origin and intrahepatic non-mass-forming cholangiocarcinoma in patients with extrabiliary malignancy
To assess the differences in early imaging features and progression pattern on CT between intrahepatic biliary metastasis (IBM) and non-mass-forming cholangiocarcinoma (NMFC) in patients with extrabiliary malignancy.
- 1 March 2018
- Published by Elsevier in Clinical Radiology
- Vol. 73 (3) , 321.e1-321.e10
Integration of different criteria for borderline resectable pancreatic cancer using classification tree analysis: the use of radiological tumour–vascular interface in correlation with surgical and pathological outcomes
- 1 March 2018
- Published by Elsevier in Clinical Radiology
- Vol. 73 (3) , 321.e1-321.e10
Integration of different criteria for borderline resectable pancreatic cancer using classification tree analysis: the use of radiological tumour–vascular interface in correlation with surgical and pathological outcomes
- 1 December 2017
- Published by Elsevier in Clinical Radiology
- Vol. 72 (12) , 1076-1084
Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma
- 1 December 2017
- Published by Elsevier in Clinical Radiology
- Vol. 72 (12) , 1076-1084
Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma
- 1 June 2017
- Published by Elsevier in Clinical Radiology
- Vol. 72 (6) , 473-481
Risk factor assessment to predict the likelihood of a diagnosis of metastasis for indeterminate hepatic lesions found at computed tomography in patients with rectal cancer
- 1 June 2017
- Published by Elsevier in Clinical Radiology
- Vol. 72 (6) , 473-481
Risk factor assessment to predict the likelihood of a diagnosis of metastasis for indeterminate hepatic lesions found at computed tomography in patients with rectal cancer
- 3 April 2017
- Published by Springer Nature in European Radiology
- Vol. 27 (10) , 4394-4405
Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging
To assess major imaging features of Liver Imaging Reporting and Data System (LI-RADS) on contrast-enhanced CT and gadoxetic acid-enhanced MRI and to estimate whether the combination of signal intensity favouring HCC on hepatobiliary phase (HBP) and diffusion-weighted images (DWI) can act as a major feature in LI-RADS.
- 3 April 2017
- Published by Springer Nature in European Radiology
- Vol. 27 (10) , 4394-4405
Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging
To assess major imaging features of Liver Imaging Reporting and Data System (LI-RADS) on contrast-enhanced CT and gadoxetic acid-enhanced MRI and to estimate whether the combination of signal intensity favouring HCC on hepatobiliary phase (HBP) and diffusion-weighted images (DWI) can act as a major feature in LI-RADS.
- 13 January 2017
- Published by SAGE Publications in Acta Radiologica
- Vol. 58 (10) , 1157-1166
Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with “high-risk stigmata” of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness
Background: It is debated whether diagnostic performance of diffusion-weighted imaging (DWI), which is widely used for detection and characterization of various malignant tumors, is comparable with high-risk stigmata of 2012 international consensus guidelines (ICG) for diagnosis of intraductal papillary mucinous neoplasms (IPMNs). Purpose: To evaluate the diagnostic accuracy of diffusion restriction in IPMNs for prediction of malignancy and invasiveness in comparison with high-risk stigmata of 2012 ICG. Material and Methods: This retrospective study was institutional review board approved and informed consent was waived. A total of 132 patients with surgically proven IPMNs (49 malignant, 83 benign) who underwent gadoxetic acid-enhanced magnetic resonance imaging (MRI), magnetic resonance cholangiopancreatography (MRCP), and DWI with a b-value of 0, 100, and 800 s/mm2 using a 3.0 T MR system were included. Two radiologists independently evaluated imaging parameters of high-risk stigmata and worrisome features of 2012 ICG and diffusion restriction in IPMNs. Univariate and multivariate logistic regression analyses and McNemar’s test were used for statistical analysis. Results: The presence of diffusion restriction in IPMNs was the only independent imaging parameter for prediction of malignancy (odds ratio [OR], 11.98; 95% confidence interval [CI], 3.60–39.87; P < 0.001) and invasiveness (OR, 17.92; 95% CI, 3.91–82.03; P < 0.001) on multivariate analysis. The diagnostic accuracy and specificity of diffusion restriction were significantly improved compared to high-risk stigmata of 2012 ICG to prediction of malignant ( P = 0.006 and P < 0.001, respectively) or invasive IPMNs ( P = 0.009 and P = 0.015, respectively). Conclusion: The diffusion restriction in IPMNs could be considered as another high-risk stigma of malignancy and predictor for invasiveness.
- 13 January 2017
- Published by SAGE Publications in Acta Radiologica
- Vol. 58 (10) , 1157-1166
Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with “high-risk stigmata” of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness
Background: It is debated whether diagnostic performance of diffusion-weighted imaging (DWI), which is widely used for detection and characterization of various malignant tumors, is comparable with high-risk stigmata of 2012 international consensus guidelines (ICG) for diagnosis of intraductal papillary mucinous neoplasms (IPMNs). Purpose: To evaluate the diagnostic accuracy of diffusion restriction in IPMNs for prediction of malignancy and invasiveness in comparison with high-risk stigmata of 2012 ICG. Material and Methods: This retrospective study was institutional review board approved and informed consent was waived. A total of 132 patients with surgically proven IPMNs (49 malignant, 83 benign) who underwent gadoxetic acid-enhanced magnetic resonance imaging (MRI), magnetic resonance cholangiopancreatography (MRCP), and DWI with a b-value of 0, 100, and 800 s/mm2 using a 3.0 T MR system were included. Two radiologists independently evaluated imaging parameters of high-risk stigmata and worrisome features of 2012 ICG and diffusion restriction in IPMNs. Univariate and multivariate logistic regression analyses and McNemar’s test were used for statistical analysis. Results: The presence of diffusion restriction in IPMNs was the only independent imaging parameter for prediction of malignancy (odds ratio [OR], 11.98; 95% confidence interval [CI], 3.60–39.87; P < 0.001) and invasiveness (OR, 17.92; 95% CI, 3.91–82.03; P < 0.001) on multivariate analysis. The diagnostic accuracy and specificity of diffusion restriction were significantly improved compared to high-risk stigmata of 2012 ICG to prediction of malignant ( P = 0.006 and P < 0.001, respectively) or invasive IPMNs ( P = 0.009 and P = 0.015, respectively). Conclusion: The diffusion restriction in IPMNs could be considered as another high-risk stigma of malignancy and predictor for invasiveness.
- 10 August 2016
- Published by Springer Nature in European Radiology
- Vol. 27 (4) , 1722-1732
Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping
- 10 August 2016
- Published by Springer Nature in European Radiology
- Vol. 27 (4) , 1722-1732
Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping
- 1 July 2016
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 89 (1063) , 20160054
The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses
Objective:To assess the value of contrast-enhanced dynamic and diffusion-weighted (DW) magnetic resonance (MR) imaging for differentiating malignant from benign splenic lesions.Methods:This retrospective study included 51 patients with 35 benign and 16 malignant focal splenic lesions. All patients underwent contrast-enhanced dynamic and DW MR imaging. Two radiologists evaluated the MR images in consensus. Significant imaging findings on univariate and multivariate analyses were identified and their diagnostic performance for predicting malignant splenic lesion was analyzed. Using receiver operating characteristic (ROC) analysis, the optimal cut-off of the apparent diffusion coefficient (ADC) value corresponding to the maximal Youden’s index (J) for differentiating two groups was determined.Results:In univariate analysis, low signal intensity (SI) on arterial, portal, and 3 minute-delayed phase images, high or iso SI on DW image, iso or low SI on ADC map, the presence of diffusion restriction, and arterial...
- 1 July 2016
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 89 (1063) , 20160054
The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses
Objective:To assess the value of contrast-enhanced dynamic and diffusion-weighted (DW) magnetic resonance (MR) imaging for differentiating malignant from benign splenic lesions.Methods:This retrospective study included 51 patients with 35 benign and 16 malignant focal splenic lesions. All patients underwent contrast-enhanced dynamic and DW MR imaging. Two radiologists evaluated the MR images in consensus. Significant imaging findings on univariate and multivariate analyses were identified and their diagnostic performance for predicting malignant splenic lesion was analyzed. Using receiver operating characteristic (ROC) analysis, the optimal cut-off of the apparent diffusion coefficient (ADC) value corresponding to the maximal Youden’s index (J) for differentiating two groups was determined.Results:In univariate analysis, low signal intensity (SI) on arterial, portal, and 3 minute-delayed phase images, high or iso SI on DW image, iso or low SI on ADC map, the presence of diffusion restriction, and arterial...